Poxel Logo

Poxel

POXEL | PA

Overview

Corporate Details

ISIN(s):
FR0012432516
LEI:
9695003OIX0T7NX72N26
Country:
France
Address:
259 AVENUE JEAN JAURES, 69007 LYON
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Poxel is a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare disorders. Poxel has clinical and earlier-stage programs from its adenosine monophosphate-activated protein kinase (AMPK) activator and deuterium-modified thiazolidinedione (dTZD) platforms targeting chronic and rare metabolic diseases. Poxel’s first-in-class lead product, TWYMEEG® (Imeglimin), that targets mitochondrial dysfunction, has been approved for the treatment of type 2 diabetes in Japan.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-08 17:45
Delisting Announcement
Inside Information / Other news releases
English 109.8 KB
2025-08-08 17:45
Legal Proceedings Report
Informations privilégiées / Autres communiqués
French 96.7 KB
2025-08-01 07:30
Legal Proceedings Report
Inside Information / Other news releases
English 134.8 KB
2025-08-01 07:30
Board/Management Information
Informations privilégiées / Autres communiqués
French 164.3 KB
2025-07-08 18:46
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
French 110.8 KB
2025-06-30 18:32
Pre-Annual General Meeting Information
Inside Information / Other news releases
English 109.4 KB
2025-06-30 18:32
Regulatory News Service
Informations privilégiées / Autres communiqués
French 95.0 KB
2025-06-06 19:05
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
French 76.2 KB
2025-05-28 07:30
Earnings Release
Inside Information / Other news releases
English 95.0 KB
2025-05-28 07:30
Regulatory News Service
Informations privilégiées / Autres communiqués
French 119.8 KB
2025-05-26 18:00
Regulatory News Service
Inside Information / Other news releases
English 98.0 KB
2025-05-26 18:00
Environmental & Social Information
Informations privilégiées / Autres communiqués
French 86.7 KB
2025-05-13 07:30
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 153.8 KB
2025-05-13 07:30
Earnings Release
Inside Information / Information on annual revenues
English 130.6 KB
2025-05-06 17:45
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
French 84.4 KB

Insider Transactions

Date Insider Name Position Type Shares Value
2024-01-29 N/A Other Buy 80,000 N/A

Peer Companies